[1] 2023 Alzheimer’s disease facts and figures[J]. AlzheimersDement,2023,19(4):1598-1695.
 [2] Zhang J, Zhang Y, Wang J, et al. Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies[J]. Signal transduction and targeted therapy, 2024, 9(1): 211.
 [3] Tzavellas N P, Tsamis K I, Katsenos A P, et al. Firing Alterations of Neurons in Alzheimer’s Disease: Are They Merely a Consequence of Pathogenesis or a Pivotal Component of Disease Progression?[J]. Cells, 2024, 13(5): 434.
 [4] Otero-Garcia M, Mahajani S U, Wakhloo D, et al. Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease[J]. Neuron, 2022, 110(18): 2929-2948. e8.
 [5] Jie F, Yang X, Yang B, et al. Stigmasterol attenuates inflammatory response of microglia via NF-κB and NLRP3 signaling by AMPK activation[J]. Biomedicine & pharmacotherapy, 2022, 153: 113317.
 [6] D’alessandro M C B, Kanaan S, Geller M, et al. Mitochondrial dysfunction in Alzheimer’s disease[J]. Ageing Research Reviews, 2025: 102713.
 [7] Chen Z R, Huang J B, Yang S L, et al. Role of cholinergic signaling in Alzheimer’s disease[J]. Molecules, 2022, 27(6): 1816.
 [8] Mehta R I, Mehta R I. The vascular-immune hypothesis of Alzheimer’s disease[J]. Biomedicines, 2023, 11(2): 408.
 [9] Kesika P, Suganthy N, Sivamaruthi B S, et al. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer’s disease[J]. Life sciences, 2021, 264: 118627.
 [10] Cammann D, Lu Y, Cummings M J, et al. Genetic correlations between Alzheimer’s disease and gut microbiome genera[J]. Scientific Reports, 2023, 13(1): 5258.
 [11] Liao W, Wei J, Liu C, et al. Magnesium-L-threonate treats Alzheimer’s disease by modulating the microbiota-gut-brain axis[J]. Neural Regeneration Research, 2024, 19(10): 2281-2289.
 [12] Bano N, Khan S, Ahamad S, et al. Microglia and gut microbiota: A double-edged sword in Alzheimer’s disease[J]. Ageing Research Reviews, 2024, 101: 102515.
 [13] Qu S, Yu Z, Zhou Y, et al. Gut microbiota modulates neurotransmitter and gut-brain signaling[J]. Microbiological Research, 2024, 287: 127858.
 [14]虞夏晖.基于药物-肠道菌群相互作用的大黄蔥酰苷抗缺血性脑损伤作用研究[D].浙江中医药大学,2019.
 [15]郑艳艳,傅月朦,郭晶晶,等.人参皂苷、人参多糖及两者联用抗乳腺癌的作用机制[J/OL].中成药,1-11[2025-08-03].https://link.cnki.net/urlid/31.1368.
 [16]陈梦婕,刘艺敏,周云,等.基于肠道菌群和代谢组学研究黄连素和黄芩苷配比对湿热内蕴型2型糖尿病粪菌移植小鼠的影响[J].中国实验方剂学杂志,2025,31(05):52-64.
 [17]黄文武,彭颖,王梦月,等.四君子汤及其单味药水煎液对脾虚大鼠肠道菌群的调节作用[J].中国实验方剂学杂志,2019,25(11):8-15.
 [18]赵一点,付强,邓夏烨,等.基于脑-肠轴探讨调胃承气汤治疗脑缺血模型大鼠作用机制研究[J].辽宁中医药大学学报,2022,24(08):15-19.
 [19] Mou Y, Du Y, Zhou L, et al. Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging[J]. Frontiers in immunology, 2022, 13: 796288.
 [20]张格,吴民民,朱路文.基于胆汁酸代谢探讨中医药治疗精神疾病的研究进展[J].中南药学,2025,23(05):1357-1362.
 [21]刘涛,欧阳林旗,陈镇,等.中药调控色氨酸-肠道菌群代谢治疗溃疡性结肠炎的研究进展[J].湖南中医药大学学报,2022,42(02):324-331.
 [22]张杰,王旭,宋晓雨,等.基于肠道菌群与代谢组学探讨补肾通腑方对AD小鼠神经炎症的影响[J].中国药理学通报,2024,40(07):1258-1266.
 [23] Song M, Zhang S, Gan Y, et al. Poria cocos Polysaccharide Reshapes Gut Microbiota to Regulate Short-Chain Fatty Acids and Alleviate Neuroinflammation-Related Cognitive Impairment in Alzheimer’s Disease[J]. Journal of Agricultural and Food Chemistry, 2025, 73(17): 10316-10330.
 [24]苏明阳,李倩倩,梁怡,等.基于肠道菌群探讨中医药调控阿尔茨海默病相关信号通路研究进展[J].陕西中医,2023,44(08):1153-1156.
 [25] Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer’s disease[J]. Neurobiology of disease, 2017, 107: 41-56.
 [26]刘晶,陈康,周渝顺,等.参芎黄连解毒汤对阿尔茨海默病模型小鼠神经元损伤和Aβ清除的影响[J].中国实验方剂学杂志,2025,31(07):43-52.
 [27] Han Y, Chen R, Lin Q, et al. Curcumin improves memory deficits by inhibiting HMGB1‐RAGE/TLR4‐NF‐κB signalling pathway in APPswe/PS1dE9 transgenic mice hippocampus[J]. Journal of Cellular and Molecular Medicine, 2021, 25(18): 8947-8956.
 [28] Liu Y, Li H, Wang X, et al. Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacology[J]. Journal of 
translational medicine, 2023, 21(1): 277.
 [29]陈怡琴,杨娇,裴文丽,等.黑逍遥散对APP/PS1小鼠认知障碍及其肠道菌群的调节作用[J/OL].中国实验方剂学杂志,1-18[2025-08-04].https://doi.org/10.13422/j.cnki.syfjx.20250905.
 [30] Sun C, Dong S, Chen W, et al. Berberine alleviates Alzheimer’s disease by regulating the gut microenvironment, restoring the gut barrier and brain-gut axis balance[J]. Phytomedicine, 2024, 129: 155624.
 [31] Feng Y, Yu X, Han J. Quercetin Regulates the Polarization of Microglia through the NRF2/HO1 Pathway and Mitigates Alzheimer’s Disease[J]. Actas Españolas de Psiquiatría, 2024, 52(6): 786.
 [32]章时杰,许婷婷,王奇.藁本内酯通过调节脑微血管内皮细胞GLUT1改善APP/PS1小鼠Aβ转运[J].神经药理学报,2019,9(04):52.
 [33]任德琳,魏玉婷,苏明莉,朱田田,严兴科.针刺调节突触可塑性治疗阿尔茨海默病机制的研究进展[J].针刺研究,2024(08):858-866.